Gossamer Bio GOSS
NASDAQ GOSS
$9.79 +0.21 (+2.19%)
At close: Oct 21, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) Short term Debt (2022 - 2026)

Updated

Gossamer Bio (GOSS) reported Short term Debt of $36.15 million for Q2 2026.

Analysis

Gossamer Bio (GOSS) Short term Debt (2022 - 2026) Analysis & Trends

At the end of FY2023, Gossamer Bio posted Short term Debt of $11.61 million, unchanged from FY2022.

  • By year, Short term Debt came in at $11.61 million in FY2022.
  • The Q2 2026 figure ranks as the lowest quarterly Short term Debt since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Gossamer Bio 39.44 Mn -433.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 36.15 Mn
Mar 31, 2024 9.59 Mn
Dec 31, 2023 11.61 Mn
Sep 30, 2023 11.61 Mn
Jun 30, 2023 11.61 Mn
Mar 31, 2023 11.61 Mn
Dec 31, 2022 11.61 Mn
API Access

Gossamer Bio Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=GOSS&period=max&api_key=YOUR_API_KEY